US 12319724
IL2 agonists and methods of use thereof
granted A61KA61K2039/505A61K2039/585
Quick answer
US patent 12319724 (IL2 agonists and methods of use thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Jun 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K2039/505, A61K2039/585, A61K2239/50, A61K2239/55